Sofie Lock Johansson

558 total citations
29 papers, 351 citations indexed

About

Sofie Lock Johansson is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Dermatology. According to data from OpenAlex, Sofie Lock Johansson has authored 29 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 16 papers in Physiology and 4 papers in Dermatology. Recurrent topics in Sofie Lock Johansson's work include Asthma and respiratory diseases (15 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (11 papers) and Respiratory and Cough-Related Research (8 papers). Sofie Lock Johansson is often cited by papers focused on Asthma and respiratory diseases (15 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (11 papers) and Respiratory and Cough-Related Research (8 papers). Sofie Lock Johansson collaborates with scholars based in Denmark, United Kingdom and Czechia. Sofie Lock Johansson's co-authors include Grith Lykke Sørensen, Jørgen Vestbo, Uffe Holmskov, Helle Wulf-Johansson, Anders Schlosser, Susanne Gjørup Sækmose, Ida Tornøe, Ole Hilberg, Celeste Porsbjerg and Linda Makowska Rasmussen and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and CHEST Journal.

In The Last Decade

Sofie Lock Johansson

23 papers receiving 349 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sofie Lock Johansson Denmark 10 178 136 58 51 41 29 351
J Chlumský Czechia 10 309 1.7× 241 1.8× 55 0.9× 38 0.7× 32 0.8× 42 435
Tomohiko Taniai Japan 13 65 0.4× 120 0.9× 38 0.7× 102 2.0× 82 2.0× 60 387
Eugenia Papakrivopoulou United Kingdom 10 58 0.3× 51 0.4× 135 2.3× 67 1.3× 17 0.4× 13 328
Eleni Bibaki Greece 10 261 1.5× 82 0.6× 102 1.8× 22 0.4× 47 1.1× 16 370
Nobuhiko Shimizu Japan 11 42 0.2× 38 0.3× 90 1.6× 88 1.7× 17 0.4× 41 298
Melanie Cotter Ireland 8 55 0.3× 40 0.3× 71 1.2× 18 0.4× 16 0.4× 26 252
Maria del Carmen Sancho‐Serra Netherlands 6 56 0.3× 81 0.6× 46 0.8× 54 1.1× 12 0.3× 7 343
Saskia Merkel Germany 6 136 0.8× 19 0.1× 61 1.1× 81 1.6× 20 0.5× 9 356
Reina Sekiya Japan 9 130 0.7× 32 0.2× 32 0.6× 23 0.5× 20 0.5× 16 268
Lindsay J. Celada United States 10 187 1.1× 216 1.6× 101 1.7× 19 0.4× 60 1.5× 15 349

Countries citing papers authored by Sofie Lock Johansson

Since Specialization
Citations

This map shows the geographic impact of Sofie Lock Johansson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sofie Lock Johansson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sofie Lock Johansson more than expected).

Fields of papers citing papers by Sofie Lock Johansson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sofie Lock Johansson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sofie Lock Johansson. The network helps show where Sofie Lock Johansson may publish in the future.

Co-authorship network of co-authors of Sofie Lock Johansson

This figure shows the co-authorship network connecting the top 25 collaborators of Sofie Lock Johansson. A scholar is included among the top collaborators of Sofie Lock Johansson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sofie Lock Johansson. Sofie Lock Johansson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Håkansson, Kjell Erik Julius, Johannes Martin Schmid, Sofie Lock Johansson, et al.. (2025). Clinical response and remission in patients treated with dupilumab for severe asthma: Results from the nationwide Danish Severe Asthma Register. Respiratory Medicine. 245. 108203–108203. 3 indexed citations
2.
Hansen, Susanne, Anna von Bülow, Ole Hilberg, et al.. (2025). Pre-biologic disease trajectories are associated with morbidity burden and biologic treatment response in severe asthma. European Respiratory Journal. 65(4). 2401497–2401497. 6 indexed citations
3.
Håkansson, Kjell Erik Julius, Susanne Hansen, Johannes Martin Schmid, et al.. (2025). Biologic Prescription Patterns and Biomarker Determinants of First‐Line Dupilumab in Danish Adult Patients With Severe Asthma and Comorbid Atopic Dermatitis. Clinical & Experimental Allergy. 55(12). 1208–1218.
4.
Håkansson, Kjell Erik Julius, Rikke Ibsen, Anna von Bülow, et al.. (2025). The impact of biologic therapy on work capacity and workforce attachment in patients with severe asthma. Journal of Asthma. 62(7). 1246–1256. 2 indexed citations
5.
Håkansson, Kjell Erik Julius, Susanne Hansen, Anna von Bülow, et al.. (2025). Long-term efficacy but rare sustained remission: individual-level 5-year stability in anti-IL5/Rα biologic therapy response for severe asthma. European Respiratory Journal. 67(3). 2500926–2500926.
6.
Håkansson, Kjell Erik Julius, Rikke Ibsen, Susanne Hansen, et al.. (2025). Financial burden of productivity loss in severe asthma and impact of biologic therapy. Pulmonology. 31(1). 2532973–2532973.
7.
8.
Håkansson, Kjell Erik Julius, Susanne Hansen, Johannes Martin Schmid, et al.. (2025). Tezepelumab in Real-Life Practice: Characteristics of Patients Commenced and Efficacy in a Nationwide, Danish Cohort of Patients With Severe Asthma. The Journal of Allergy and Clinical Immunology In Practice. 14(2). 418–426. 1 indexed citations
9.
Harboe, Zitta Barrella, Andrea Browatzki, Christian Niels Meyer, et al.. (2025). Study protocol: COPD–eosinophil-guided reduction of inhaled corticosteroids (COPERNICOS). Trials. 26(1). 335–335.
10.
Rasmussen, Linda Makowska, Sofie Lock Johansson, Ole Hilberg, et al.. (2024). Titration of anti-IL-5 biologics in severe asthma: an open-label randomised controlled trial (the OPTIMAL study). European Respiratory Journal. 64(2). 2400404–2400404. 7 indexed citations
11.
Henriksen, Daniel Pilsgaard, Per Damkier, Karoline Schousboe, et al.. (2024). Network of doctors for multimorbidity and diabetes — the NOMAD intervention: protocol for feasibility trial of multidisciplinary team conferences for people with diabetes and multimorbidity. Pilot and Feasibility Studies. 10(1). 91–91. 1 indexed citations
12.
Bülow, Anna von, Johannes Martin Schmid, Linda Makowska Rasmussen, et al.. (2023). Clinical Response and Remission in Patients With Severe Asthma Treated With Biologic Therapies. CHEST Journal. 165(2). 253–266. 56 indexed citations
13.
Sivapalan, Pradeesh, et al.. (2023). Incidence of community-acquired pneumonia hospitalisation in persons with bronchiectasis during the COVID-19 lockdown in Denmark: a retrospective cohort study. BMJ Open Respiratory Research. 10(1). e001517–e001517. 1 indexed citations
14.
Hansen, Susanne, Anna von Bülow, Ole Hilberg, et al.. (2023). Tobacco Exposure and Efficacy of Biologic Therapy in Patients With Severe Asthma: A Nationwide Study From the Danish Severe Asthma Register. The Journal of Allergy and Clinical Immunology In Practice. 12(1). 146–155.e5. 9 indexed citations
15.
Eklöf, Josefin, Pradeesh Sivapalan, Truls Sylvan Ingebrigtsen, et al.. (2023). Inhaled Corticosteroids in Patients with Chronic Obstructive Pulmonary Disease and Risk of Acquiring Streptococcus pneumoniae Infection. A Multiregional Epidemiological Study. International Journal of COPD. Volume 18. 373–384. 2 indexed citations
16.
Christoffersen, Mette, Hanne Lindegaard, Jesper Rømhild Davidsen, et al.. (2023). The multidisciplinary approach to eosinophilia. Frontiers in Oncology. 13. 1193730–1193730. 13 indexed citations
17.
Johansson, Sofie Lock, Helle Wulf-Johansson, Anders Schlosser, et al.. (2019). Plasma microfibrillar-associated protein 4 is not prognostic of emphysema progression but is associated with cardiovascular disease history and mortality in COPD patients. ERJ Open Research. 5(2). 21–2019. 3 indexed citations
18.
Sækmose, Susanne Gjørup, Anders Schlosser, René Holst, et al.. (2013). Enzyme-Linked Immunosorbent Assay Characterization of Basal Variation and Heritability of Systemic Microfibrillar-Associated Protein 4. PLoS ONE. 8(12). e82383–e82383. 19 indexed citations
19.
Wulf-Johansson, Helle, Sofie Lock Johansson, Anders Schlosser, et al.. (2013). Localization of Microfibrillar-Associated Protein 4 (MFAP4) in Human Tissues: Clinical Evaluation of Serum MFAP4 and Its Association with Various Cardiovascular Conditions. PLoS ONE. 8(12). e82243–e82243. 70 indexed citations
20.
Wulf-Johansson, Helle, Mikael Thinggaard, Qihua Tan, et al.. (2012). Circulating surfactant protein D is associated to mortality in elderly women: A twin study. Immunobiology. 218(5). 712–717. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J Chlumský Breakdown of academic impact, for papers by Tomohiko Taniai Breakdown of academic impact, for papers by Eugenia Papakrivopoulou Breakdown of academic impact, for papers by Eleni Bibaki Breakdown of academic impact, for papers by Nobuhiko Shimizu Breakdown of academic impact, for papers by Melanie Cotter Breakdown of academic impact, for papers by Maria del Carmen Sancho‐Serra Breakdown of academic impact, for papers by Saskia Merkel Breakdown of academic impact, for papers by Reina Sekiya Breakdown of academic impact, for papers by Lindsay J. Celada
Rankless by CCL
2026